SCHEMBL10035624

SCHEMBL10035624

COc1cc2c(cc1OC)CN(CCCNS(=O)(=O)c1ccc(C)cc1)CC2

nearest known ligand 0.79

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MBTD1 Q05BQ5 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
HTR7 P34969 4/20 0.57
SIGMAR1 Q99720 2/20 0.57
TMEM97 Q5BJF2 1/20 0.57
ALDH1A1 P00352 2/20 0.57
HPGD P15428 1/20 0.57
HSD17B10 Q99714 1/20 0.57
HTR1A P08908 1/20 0.56
HTR2A P28223 1/20 0.56
SLC6A4 P31645 1/20 0.56
HTR2B P41595 1/20 0.56
KCNH2 Q12809 1/20 0.56
DRD2 P14416 1/20 0.55
DRD3 P35462 1/20 0.55
ABCB1 P08183 2/20 0.54
NPSR1 Q6W5P4 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2138894 0.99 MBTD1 (0.58) MBTD1L3MBTL1HTR7SIGMAR1TMEM97
SCHEMBL4230235 0.97 SIGMAR1 (0.62) MBTD1L3MBTL1HTR7SIGMAR1TMEM97
SCHEMBL10035595 0.92 ABCB1 (0.64) HTR7ALDH1A1HTR1AHTR2ADRD3
SCHEMBL2138032 0.92 HTR7 (0.57) HTR7SIGMAR1TMEM97ABCB1
Hydrochloric Acid SCHEMBL2141854 0.91 ABCB1 (0.63) HTR7ALDH1A1HTR1AHTR2AABCB1
SCHEMBL10035577 0.91 HTR1A (0.57) HTR7TMEM97ALDH1A1HTR1AHTR2A
SCHEMBL10035558 0.91 HTR7 (0.56) HTR7HTR2ADRD2DRD3ABCB1
SCHEMBL5402012 0.90 HTR7 (0.71) HTR7SIGMAR1TMEM97ABCB1
SCHEMBL10035598 0.90 POLB (0.62) HTR7SIGMAR1TMEM97DRD2DRD3
Hydrochloric Acid SCHEMBL2140245 0.90 HTR7 (0.55) HTR7HTR1AHTR2AHTR2BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148397-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-04-03 US disclosed
US-8148397-B2 5-HT7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-04-03 US disclosed
US-20090088450-A1 5-ht7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2009-04-02 US disclosed
US-20090088450-A1 5-ht7 receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088450-A1 5-ht7 receptor antagonists HTR7, HTR1A, HTR5A MBTD1 1875/4885L3MBTL1 4246/4885HTR7 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.